Glargine and degludec: Solution behaviour of higher dose synthetic insulins.

ADAMS, Gary G, ALZAHRANI, Qushmua, JIWANI, Shahwar I, MEAL, Andrew, MORGAN, Paul S, COFFEY, Frank, KOK, Samil, ROWE, Arthur J, HARDING, Stephen E, CHAYEN, Naomi and GILLIS, Richard B (2017). Glargine and degludec: Solution behaviour of higher dose synthetic insulins. Scientific reports, 7 (1): 7287.

[img]
Preview
PDF
Gillis-GlargineAndDegludec(VoR).pdf - Published Version
Creative Commons Attribution.

Download (2MB) | Preview
Official URL: https://www.nature.com/articles/s41598-017-06642-w
Open Access URL: https://www.nature.com/articles/s41598-017-06642-w... (Published version)
Link to published version:: https://doi.org/10.1038/s41598-017-06642-w

Abstract

Single, double and triple doses of the synthetic insulins glargine and degludec currently used in patient therapy are characterised using macromolecular hydrodynamic techniques (dynamic light scattering and analytical ultracentrifugation) in an attempt to provide the basis for improved personalised insulin profiling in patients with diabetes. Using dynamic light scattering and sedimentation velocity in the analytical ultracentrifuge glargine was shown to be primarily dimeric under solvent conditions used in current formulations whereas degludec behaved as a dihexamer with evidence of further association of the hexamers ("multi-hexamerisation"). Further analysis by sedimentation equilibrium showed that degludec exhibited reversible interaction between mono- and-di-hexamer forms. Unlike glargine, degludec showed strong thermodynamic non-ideality, but this was suppressed by the addition of salt. With such large injectable doses of synthetic insulins remaining in the physiological system for extended periods of time, in some case 24-40 hours, double and triple dose insulins may impact adversely on personalised insulin profiling in patients with diabetes.

Item Type: Article
Uncontrolled Keywords: Humans; Insulin, Long-Acting; Blood Glucose; Hypoglycemic Agents; Tissue Distribution; Hydrodynamics; Dynamic Light Scattering; Insulin Glargine; Blood Glucose; Dynamic Light Scattering; Humans; Hydrodynamics; Hypoglycemic Agents; Insulin Glargine; Insulin, Long-Acting; Tissue Distribution
Identification Number: https://doi.org/10.1038/s41598-017-06642-w
SWORD Depositor: Symplectic Elements
Depositing User: Symplectic Elements
Date Deposited: 02 May 2023 15:08
Last Modified: 11 Oct 2023 15:30
URI: https://shura.shu.ac.uk/id/eprint/31108

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics